CompletedNot Applicable

Central Catheters Used for Chemotherapy in Women With Breast Cancer

Sweden250 participantsStarted 2016-04-01

Plain-language summary

The overall aim of this study is to evaluate two different central venous lines, PICC-lines (PICC) and subcutaneous venous access ports (SVAP) used for chemotherapy in women with breast cancer. The study will compare complications, material wear of the catheters used, patients'- and health care professionals' experiences, and costs. The study will give knowledge about which central venous access that is the most advantageous regarding adjuvant chemotherapy for women with breast cancer in the aspects of safety, quality of care, and quality of life.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adjuvant or neo adjuvant chemotherapy, * speak Swedish Exclusion Criteria: * cognitive dysfunction * and/or inability to understand Swedish, * recurrent breast cancer

What they're measuring

Complications

Timeframe: Through study completion up to 18 weeks

Trial details

NCT IDNCT04324346

SponsorSwedish Red Cross University College

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-02-01

View on ClinicalTrials.gov More Catheter Related Complications trials